Prostate Cancer - Results from #380

The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy. August 26, 2024

Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml. August 26, 2024

Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer. August 26, 2024

Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer. August 26, 2024

Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer. August 23, 2024

Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial. August 23, 2024

Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis. August 23, 2024

How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial. August 23, 2024

Clinical Factors That Influence Repeat 68Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study. August 23, 2024

HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES. August 23, 2024

Current therapy and drug resistance in metastatic castration-resistant prostate cancer. August 23, 2024

Clarity receives FDA Fast Track Designation for 64Cu-SAR- bisPSMA August 22, 2024

Suicide Attempt and Suicide Death Among Spouses of Patients With Cancer August 22, 2024

Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men with Biochemically Recurrent Prostate Cancer August 22, 2024

Radiotherapy and immunology August 22, 2024

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial. August 22, 2024

Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake. August 22, 2024

PSMA-Targeted 2-Deoxyglucose-Based Dendrimer Nanomedicine for the Treatment of Prostate Cancer. August 22, 2024

Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genes. August 22, 2024

Prostate-specific antigen and health-related quality of life in individuals with advanced prostate cancer treated with apalutamide: a plain language summary of the SPARTAN and TITAN studies. August 22, 2024

Page 20 of 1436